Observed arrival · 2026-10-21
Radar Parkinson tracks treatments beyond dopamine replacement
A multilingual, patient-facing guide to experimental treatments aiming to slow, repair, or prevent Parkinson’s, with rankings, charts, and plain-language explainers.
○Open
⊠Login
$Paid
†Ads
✦Pretty
●Pro
◎Niche
◉Human
⚑Risk
ƒJS
- For
- Patients and families tracking Parkinson treatment research
- Worth noticing
- Its index starts from historical neurological-drug approval rates—about 7%, 12%, and 45% across phases 1–3—and adjusts for evidence.
Field notes
The page distinguishes disease-modifying approaches from dopamine-replacement medicines, and includes a prevention filter for an early trial. Its methodology section says maturity, safety, and accessibility count less when evidence is weak, and that phase-based approval estimates are adjusted to reflect evidence. The extracted view currently reports no treatments for the active filters, so it does not expose the underlying entries.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
○OpenPublic substance visible
✦PrettyNotable craft visible
●ProPolished or operationally mature
◎NicheUnusually specific use
One card from the complete issue